Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.

I Eriksson, B; Ekman, S; Lindbratt, S; Baur, M; Bach, D; Torholm, C; Kälebo, P; Close, P

doi:10.2106/00004623-199703000-00002

Public

Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.

Shared by NobleBlocks on Mar 1, 1997 • 12:00 AM UTC

Authors:

B I Eriksson

S Ekman

S Lindbratt

Abstract

Specific inhibition of thrombin is a new method for the prevention of postoperative deep-vein thrombosis. The objective of this multicenter, randomized, double-blind study was to compare the efficacy and safety of desirudin (Revasc, CGP 39393; fifteen milligrams two times a day) with that of unfract...

Discussions